Related Experiment Videos

Mesangial myofibroblastic transformation in steroid-dependent minimal change nephrotic syndrome

K Naruse1, M Fujieda, E Miyazaki

  • 1First Department of Pathology, Kochi Medical School, Kohasu Okohcho, Nankoku 783-8505, Japan. chip@i-kochi.or.jp

Medical Electron Microscopy : Official Journal of the Clinical Electron Microscopy Society of Japan
|January 26, 2002
PubMed

Insights

Minimal change nephrotic syndrome (MCNS) patients with frequent relapses show myofibroblastic transformation in glomerular mesangial cells. This transformation, marked by alpha-smooth muscle actin (ASMA) and vimentin, is not visible with standard microscopy.

Area of Science:

  • Nephrology
  • Pathology
  • Immunohistochemistry

Background:

  • Minimal change nephrotic syndrome (MCNS) can present with frequent relapses and proteinuria post-steroid treatment.
  • Standard microscopy often reveals no significant glomerular abnormalities in relapsing MCNS cases, creating a diagnostic challenge.

Observation:

  • A patient with MCNS and frequent relapses underwent immunohistochemical and ultrastructural examination of renal biopsy tissue.
  • Compared to nonrelapsed MCNS cases, the patient's tissue showed overexpression of alpha-smooth muscle actin (ASMA) and vimentin in glomerular mesangial cells.

Findings:

  • Glomerular mesangial cells exhibited alpha-smooth muscle actin (ASMA) and vimentin overexpression.
  • This overexpression occurred without evidence of mesangial cell proliferation.
  • These markers indicate mesangial myofibroblastic transformation, undetectable by conventional light microscopy or immunofluorescence.

Implications:

  • The findings suggest mesangial myofibroblastic transformation may be a key factor in the pathogenesis of steroid-dependent MCNS with frequent relapses.
  • Immunohistochemical detection of ASMA and vimentin could serve as a valuable diagnostic tool for identifying this transformation.
  • This could lead to a better understanding and potentially novel therapeutic strategies for difficult-to-treat MCNS.

Related Concept Videos